217 related articles for article (PubMed ID: 205349)
21. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
Laasberg T; Pihlak A; Neuman T; Paves H; Saarma M
FEBS Lett; 1988 Nov; 239(2):367-70. PubMed ID: 2460374
[TBL] [Abstract][Full Text] [Related]
22. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
24. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
Singh R; Shankar R
Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
[No Abstract] [Full Text] [Related]
25. Cyclic nucleotide phosphodiesterases.
Wells JN; Hardman JG
Adv Cyclic Nucleotide Res; 1977; 8():119-43. PubMed ID: 200125
[No Abstract] [Full Text] [Related]
26. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
Epstein PM; Hachisu R
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124
[No Abstract] [Full Text] [Related]
27. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
Pizarro M; Puente J; Sapag-Hagar M
FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
[No Abstract] [Full Text] [Related]
28. Multiplicity within cyclic nucleotide phosphodiesterases.
Rybalkin SD; Beavo JA
Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
[No Abstract] [Full Text] [Related]
29. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
Manganiello V
Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
[No Abstract] [Full Text] [Related]
30. Cyclic nucleotide phosphodiesterases of the renal cortex. Characterization of basal-lateral membrane activities.
Filburn CR; Liang CT; Sacktor B
J Membr Biol; 1977 Oct; 37(1):29-43. PubMed ID: 21299
[No Abstract] [Full Text] [Related]
31. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
Ilien B; Landry Y
Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
[No Abstract] [Full Text] [Related]
32. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
33. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
Sobolev AS; Rybalkin SD
Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
[TBL] [Abstract][Full Text] [Related]
34. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
[No Abstract] [Full Text] [Related]
35. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
Rybalkin SD; Sobolev AS
Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
[TBL] [Abstract][Full Text] [Related]
37. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
38. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
Erneux C; Miot F
Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
[No Abstract] [Full Text] [Related]
39. Characterization of various horse thyroid forms of cyclic-nucleotide phosphodiesterase [proceedings].
Erneux C; Couchie D
Arch Int Physiol Biochim; 1979 May; 87(2):408-10. PubMed ID: 92956
[No Abstract] [Full Text] [Related]
40. Cyclic nucleotide phosphodiesterases from rat pancreas: differential regulation by a calcium-dependent activator protein [proceedings].
Vandermeers A; Vandermeers MC; Rathe J; Delforge A; Christophe J
Biochem Soc Trans; 1977; 5(4):981-2. PubMed ID: 199510
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
